XBiotech director John Simard acquires $711,251 in stock

John Simard, a director and 10% owner of XBiotech Inc. (NASDAQ:XBIT), acquired 368,524 shares of common stock on October 26, 2026. The transaction totaled $711,251, with shares purchased at a price of $1.93 each. Mr. Simard purchased these shares from Thorpe McKenzie. The purchase comes as the stock trades near its 52-week low of $1.80, with shares down 16% year-to-date. According to InvestingPro analysis, XBIT appears undervalued at current levels, with the company holding more cash than debt on its balance sheet—one of 9 ProTips available to subscribers.

Following this transaction, Mr. Simard directly holds 4,191,690 shares of XBiotech common stock. The biotech company maintains a market cap of $60.67 million and boasts a strong current ratio of 33.15, indicating solid liquidity despite burning through cash.